Creatine for Older Women: Why Training Duration May Matter

Creatine may not follow the same timeline in older women

Creatine plus resistance training appears to improve strength in older women, but the most useful gains may take longer to show up in the legs. That matters because lower-body strength supports rising from a chair, climbing stairs, and maintaining independence.

A 2021 systematic review and meta-analysis of older women found that creatine combined with resistance training significantly improved upper-body strength, measured with exercises such as the bench press and chest press. Lower-body strength, measured with leg press and hack squat, reached statistical significance only in studies lasting at least 24 weeks. The review pooled eight randomized controlled trials with 176 postmenopausal women or women aged 60 and older.

That result does not mean creatine only helps the upper body in women. It means the available female-specific trials detected upper-body improvements more consistently, while lower-body improvements appeared in the longer programs. For an older woman whose goal is stronger legs and better daily function, an eight-week supplement experiment is poorly matched to this evidence.

The mixed-sex evidence points in a different direction

The contrast becomes interesting when the female-specific analysis is set beside a 2025 meta-analysis in adults aged 50 and older. That review pooled roughly 482 participants from randomized trials published between 2015 and 2025. Compared with resistance training alone, creatine plus resistance training improved lower-extremity strength and lean tissue mass. The reported standardized mean difference for lean mass was 0.27. The analysis did not find a consistently significant effect for upper-extremity hypertrophy.

In the mixed-sex data, interventions lasting 32 weeks or less produced the strongest subgroup effects. In the older-women analysis, lower-body strength emerged only in the subgroup lasting 24 weeks or longer. These cutoffs do not measure the same thing: one review compared 32 weeks or less with longer programs, while the other used groups of 14 weeks or less and 24 weeks or longer. They cannot prove that women need more time than men.

Still, the anatomical pattern differs. The mixed-sex analysis emphasized lower-body strength and lean mass; the women-only analysis found the clearest strength result in the upper body. A reasonable interpretation is that sex may modify the response to creatine plus training. It is not proof that male participants drove the lower-body result in the mixed-sex review, because the studies did not directly randomize and compare older men and women under the same protocol.

Why biology could matter—and why the mechanism remains unproven

Creatine helps replenish phosphocreatine, a fuel system that supports short, high-intensity muscular effort. Reviews by Candow and colleagues in 2024 and 2025 discuss how aging, hormonal changes, and reduced anabolic responsiveness could affect the size of the benefit from creatine and resistance training.

The women-specific review also cites evidence that females may have higher resting intramuscular total creatine concentrations. If baseline stores are higher, supplemental creatine could create a smaller concentration gradient for uptake. Postmenopausal hormonal changes and differences in muscle-fiber characteristics offer other plausible explanations for a different response pattern.

Plausible is the operative word. No dedicated pharmacokinetic or mechanistic study has established these pathways in older women. The current evidence describes outcomes after supplementation and training; it does not show why one muscle group responds earlier than another.

Lean mass is the least settled outcome for older women

The 2021 women-only meta-analysis found no statistically significant increase in lean tissue mass. That null result should not be read as proof that creatine fails to add lean mass in older women. With 176 participants, the analysis fell below the review authors' 300-participant threshold for avoiding a GRADE downgrade for imprecision. A small benefit could have been missed, including one in the neighborhood of the 0.27 standardized mean difference reported in the larger mixed-sex analysis.

The methods also limit confidence. Three of the eight trials provided female-only data extracted after the fact from mixed-sex trials rather than from studies designed around prespecified sex-stratified analyses. The trials used several dosing approaches: a loading phase of 20 g per day for five to seven days followed by 5 g per day, a fixed 5 g per day without loading, or 0.1 g per kilogram per day. Programs lasted 12 to 52 weeks. Eight studies also fall short of the usual minimum for a formal funnel-plot assessment of publication bias.

Those limitations do not erase the strength findings. They do mean that claims about lean mass, the ideal dose, and the exact duration for women need more humility than a supplement label usually provides.

Broader nutrition meta-analyses cannot answer the sex question

A 2021 meta-analysis of resistance training plus nutritional interventions in older adults reported positive pooled effects on muscle-related outcomes. But it combined nutritional strategies and did not stratify results by sex. It therefore supports the general idea that training plus nutrition can help older adults, while offering little guidance on whether creatine produces the same lean-mass or lower-body response in older women and older men.

This is a common problem in aging research. A positive average can conceal different response patterns within the average. It is especially relevant here because the female-specific meta-analysis found a non-significant lean-mass result and a duration-dependent lower-body strength result.

What a practical protocol looks like

For older adults who can safely perform resistance training, creatine monohydrate is a reasonable addition rather than a replacement for training. The evidence base tests creatine alongside resistance exercise, not as a substitute for it.

• Older women: A daily 5 g creatine monohydrate approach without loading has been used in long-term research. If the aim is lower-body strength, plan for at least 24 weeks of consistent resistance training and supplementation before judging the result. Upper-body strength has the most consistent support at shorter durations in the female-specific meta-analysis.
• Older men: Mixed-sex evidence supports improvements in lower-extremity strength and lean tissue mass, but it does not establish a male-specific effect size or an ideal sex-specific schedule. Programs of 12 to 32 weeks fit the subgroup range with the strongest effects in the 2025 mixed-sex review.
• Everyone: Track performance, not just scale weight. Log loads, repetitions, chair-rise ability, and other relevant functional measures. Creatine-related weight changes can reflect water retained in muscle and do not by themselves show new contractile tissue.

A two-year randomized trial in 237 postmenopausal women used 5 g per day of creatine monohydrate without a loading phase during exercise. Its primary endpoint was bone mineral density, not muscle, but it provides useful duration and tolerability context for women considering a longer program.

The evidence supports creatine plus resistance training for older adults. The evidence for sex-specific timing is useful but provisional: older women may need at least six months to see lower-body strength gains, yet no head-to-head randomized trial has confirmed that this differs from men.

That uncertainty sets the right standard. Creatine is inexpensive, widely studied, and more credible than most longevity supplements, but it does not exempt anyone from progressive training, adequate protein, recovery, or medical advice when kidney disease, medications, or other health conditions complicate supplementation.